Pitcairn’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-700
| Closed | -$447K | – | 263 |
|
|
2025
Q3 | $447K | Sell |
700
-111
| -14% | -$67.4K | 0.04% | 374 |
|
|
2025
Q2 | $435K | Sell |
811
-221
| -21% | -$106K | 0.03% | 440 |
|
|
2025
Q1 | $433K | Sell |
1,032
-31
| -3% | -$13.5K | 0.03% | 467 |
|
|
2024
Q4 | $439K | Sell |
1,063
-79
| -7% | -$34.7K | 0.03% | 465 |
|
|
2024
Q3 | $577K | Sell |
1,142
-179
| -14% | -$87K | 0.03% | 391 |
|
|
2024
Q2 | $644K | Buy |
1,321
+62
| +5% | +$31.1K | 0.04% | 358 |
|
|
2024
Q1 | $680K | Buy |
1,259
+47
| +4% | +$25.7K | 0.04% | 338 |
|
|
2023
Q4 | $673K | Sell |
1,212
-10
| -0.8% | -$4.7K | 0.05% | 314 |
|
|
2023
Q3 | $534K | Buy |
1,222
+81
| +7% | +$40.4K | 0.04% | 340 |
|
|
2023
Q2 | $573K | Sell |
1,141
-22
| -2% | -$10.5K | 0.05% | 316 |
|
|
2023
Q1 | $582K | Sell |
1,163
-27
| -2% | -$12.9K | 0.05% | 309 |
|
|
2022
Q4 | $485K | Sell |
1,190
-3
| -0.3% | -$1.17K | 0.05% | 323 |
|
|
2022
Q3 | $389K | Sell |
1,193
-202
| -14% | -$74.2K | 0.04% | 353 |
|
|
2022
Q2 | $489K | Sell |
1,395
-326
| -19% | -$133K | 0.05% | 305 |
|
|
2022
Q1 | $941K | Sell |
1,721
-2,303
| -57% | -$1.21M | 0.08% | 211 |
|
|
2021
Q4 | $2.65M | Buy |
4,024
+544
| +16% | +$341K | 0.17% | 85 |
|
|
2021
Q3 | $2.16M | Buy |
3,480
+89
| +3% | +$59.8K | 0.15% | 96 |
|
|
2021
Q2 | $2.14M | Buy |
3,391
+511
| +18% | +$282K | 0.14% | 101 |
|
|
2021
Q1 | $1.41M | Buy |
2,880
+552
| +24% | +$277K | 0.1% | 144 |
|
|
2020
Q4 | $1.16M | Buy |
2,328
+696
| +43% | +$311K | 0.09% | 150 |
|
|
2020
Q3 | $642K | Buy |
1,632
+458
| +39% | +$169K | 0.05% | 218 |
|
|
2020
Q2 | $388K | Sell |
1,174
-15
| -1% | -$4.34K | 0.04% | 284 |
|
|
2020
Q1 | $288K | Sell |
1,189
-35
| -3% | -$9.13K | 0.03% | 309 |
|
|
2019
Q4 | $320K | Sell |
1,224
-122
| -9% | -$32.1K | 0.03% | 375 |
|
|
2019
Q3 | $366K | Sell |
1,346
-47
| -3% | -$13.1K | 0.04% | 320 |
|
|
2019
Q2 | $383K | Sell |
1,393
-15
| -1% | -$3.7K | 0.04% | 305 |
|
|
2019
Q1 | $315K | Sell |
1,408
-10
| -0.7% | -$2.06K | 0.03% | 340 |
|
|
2018
Q4 | $264K | Sell |
1,418
-74
| -5% | -$15.2K | 0.03% | 341 |
|
|
2018
Q3 | $372K | Sell |
1,492
-175
| -10% | -$42.5K | 0.04% | 336 |
|
|
2018
Q2 | $363K | Sell |
1,667
-1,697
| -50% | -$350K | 0.04% | 334 |
|
|
2018
Q1 | $644K | Sell |
3,364
-894
| -21% | -$165K | 0.07% | 190 |
|
|
2017
Q4 | $666K | Sell |
4,258
-2,147
| -34% | -$338K | 0.07% | 214 |
|
|
2017
Q3 | $996K | Sell |
6,405
-572
| -8% | -$90.4K | 0.11% | 129 |
|
|
2017
Q2 | $1.13M | Buy |
6,977
+1,249
| +22% | +$203K | 0.14% | 106 |
|
|
2017
Q1 | $885K | Buy |
5,728
+1,958
| +52% | +$270K | 0.11% | 138 |
|
|
2016
Q4 | $442K | Buy |
3,770
+124
| +3% | +$14.2K | 0.05% | 276 |
|
|
2016
Q3 | $411K | Buy |
+3,646
| New | +$384K | 0.05% | 287 |
|
Other funds holding IDXX
JSC
Pitcairn's IDXX Position: Q4 2025 in Review
Pitcairn sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 700 shares — an estimated $447K sold.
Pitcairn first reported a position in IDXX in Q3 2016 and held it in 37 quarters. The position peaked at $2.65M in Q4 2021. 1,385 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.
- Pitcairn reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
- Pitcairn sold 700 Idexx Laboratories shares in Q4 2025, an estimated $447K.
- Pitcairn first reported a position in Idexx Laboratories in Q3 2016 and held it in 37 quarters.
- Pitcairn's Idexx Laboratories position peaked at $2.65M in Q4 2021.
- 1,385 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.
Based on Pitcairn's 13F filing for Q4 2025.